Inner Logic develops a simulation and data platform that allows device manufacturers to design, test, and validate procedural devices across thousands of virtual patients grounded in real clinical and procedural data. The company’s infrastructure aims to shift exploratory device development from physical prototypes and cadaver labs into in silico testing to accelerate iteration and broaden patient coverage. Founders include CEO Tito Porras, MD; CTO Mathias Unberath, PhD; and Chief Robotics Officer Axel Krieger, PhD, who collectively have authored over 400 peer-reviewed publications and are named inventors on more than 40 patents. Inner Logic has demonstrated its technology by training AI in simulation for orthopedic trauma and deploying it successfully on real hardware and patient anatomy, and by completing key steps of an autonomous gallbladder removal in a live animal model. The company is positioning its platform to support the development and validation of intelligent and autonomous procedural systems as they move toward clinical deployment. The announced financial position includes an $11.5 million seed round to advance product development and scaling.

Total raised

$12M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2026